Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Huizhou Jinghao Medical Technology Co Net Margin %?
Huizhou Jinghao Medical Technology CoBJSE:920925 60 Net Margin % is 1.13% as of Jun. 2026, which is 93% below its 10-year median of 15.12. GuruFocus rates BJSE:920925 with a GF Score™ of 60/100 and a GF Value™ of ¥18.93 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Huizhou Jinghao Medical Technology Co ranks worse than 53.55% on this metric.
BJSE:920925'
s Net Margin % Range Over the Past 10 Years
Min: 0.56 Med: 15.12 Max: 20.66
Current: 0.56
BJSE:920925's Net Margin % is ranked worse than 53.55% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 2.39
vs BJSE:920925: 0.56
Huizhou Jinghao Medical Technology Co (BJSE:920925) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Huizhou Jinghao Medical Technology Co Net Margin % Related Terms
Huizhou Jinghao Medical Technology Co Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Huizhou Jinghao Medical Technology Co Net Margin % Chart
BJSE:920925 vs ABT, SYK, MDT: Net Margin % Comparison
For the Medical Devices subindustry, Huizhou Jinghao Medical Technology Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Huizhou Jinghao Medical Technology Co Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Huizhou Jinghao Medical Technology Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Huizhou Jinghao Medical Technology Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Huizhou Jinghao Medical Technology Co (BJSE:920925) has a Net Margin % of 1.13% as of Jun. 2026. Net margin is the ratio of total net income to net sales. View historical data on Huizhou Jinghao Medical Technology Co and its competitors. This is 93% below median its historical median of 15.12. Over the past decade, Huizhou Jinghao Medical Technology Co's Net Margin % has ranged from 0.56 to 20.66. According to the industry distribution chart, Huizhou Jinghao Medical Technology Co ranks #437 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 53.6%.
Is Huizhou Jinghao Medical Technology Co's Net Margin % too high?
Huizhou Jinghao Medical Technology Co's current Net Margin % of 1.13% is 93% below median its 10-year median of 15.12. Over the past 10 years, this metric has ranged from a low of 0.56 to a high of 20.66. The Medical Devices & Instruments industry median Net Margin % is 2.39. Huizhou Jinghao Medical Technology Co's value of 1.13% is 52.7% below this industry median. Based on the distribution chart, Huizhou Jinghao Medical Technology Co ranks #437 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Huizhou Jinghao Medical Technology Co has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Huizhou Jinghao Medical Technology Co's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Huizhou Jinghao Medical Technology Co ranks #437 out of 816 companies for Net Margin %. This places Huizhou Jinghao Medical Technology Co in the lower half of its industry. The industry median Net Margin % is 2.39. Huizhou Jinghao Medical Technology Co's value of 1.13% is 52.7% below this benchmark. Historically, Huizhou Jinghao Medical Technology Co's own Net Margin % has ranged from 0.56 to 20.66 over the past decade. While the company's 10-year median is 15.12 vs. the industry median of 2.39, Huizhou Jinghao Medical Technology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.39, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Huizhou Jinghao Medical Technology Co's current Net Margin % of 1.13% is 52.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Huizhou Jinghao Medical Technology Co and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Huizhou Jinghao Medical Technology Co's current Net Margin % is 1.13%, which is 93% below median its own 10-year median of 15.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huizhou Jinghao Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Huizhou Jinghao Medical Technology Co (BJSE:920925) is currently considered Possible Value Trap. The stock's GF Value™ is ¥18.93, compared to a current price of ¥12.13 — trading 35.9% below its estimated fair value. The current Net Margin % is 1.13%, which is 93% below median its 10-year median of 15.12 and 52.7% below the Medical Devices & Instruments industry median of 2.39. Huizhou Jinghao Medical Technology Co's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Huizhou Jinghao Medical Technology Co (BJSE:920925), the current Net Margin % is 1.13% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Huizhou Jinghao Medical Technology Co (BJSE:920925) Overvalued in 2026?
Based on GuruFocus' analysis, Huizhou Jinghao Medical Technology Co stock appears to be undervalued.
The current stock price of ¥12.13 is trading 35.9% below its estimated GF Value™ of ¥18.93.
GuruFocus considers Huizhou Jinghao Medical Technology Co to be Possible Value Trap.
Key valuation signals for BJSE:920925:
Net Margin %: 1.13% (93% below median its 10-year median of 15.12)
GF Value™: ¥18.93 vs. price of ¥12.13 (35.9% below fair value)
Industry Position: 52.7% below the Medical Devices & Instruments median (#437 of 816)
No single metric tells the full story. See the BJSE:920925 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920925 has been successfully added to your 
